hydrophobic interaction. Importantly, this hydrophobic interaction-based ECL strategy could be easily expanded to the bioassay of various biomarkers, providing an efficient tool for early clinical diagnosis of AMI and some other diseases.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: